Improving the Angiogenic Potential of EPCs via Engineering with Synthetic Modified mRNAs

Steinle, Heidrun; Golombek, Sonia; Behring, Andreas; Schlensak, Christian; Wendel, Hans Peter; Avci-Adali, Meltem

dc.contributor.author	Steinle, Heidrun
dc.contributor.author	Golombek, Sonia
dc.contributor.author	Behring, Andreas
dc.contributor.author	Schlensak, Christian
dc.contributor.author	Wendel, Hans Peter
dc.contributor.author	Avci-Adali, Meltem
dc.date.accessioned	2019-06-25T09:37:26Z
dc.date.available	2019-06-25T09:37:26Z
dc.date.issued	2018
dc.identifier.issn	2162-2531
dc.identifier.uri	http://hdl.handle.net/10900/89886
dc.language.iso	en	de_DE
dc.publisher	Cell Press	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.omtn.2018.09.005	de_DE
dc.subject.ddc	610	de_DE
dc.title	Improving the Angiogenic Potential of EPCs via Engineering with Synthetic Modified mRNAs	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190321153956_00075
utue.publikation.seiten	387-398	de_DE
utue.personen.roh	Steinle, Heidrun
utue.personen.roh	Golombek, Sonia
utue.personen.roh	Behring, Andreas
utue.personen.roh	Schlensak, Christian
utue.personen.roh	Wendel, Hans Peter
utue.personen.roh	Avci-Adali, Meltem
dcterms.isPartOf.ZSTitelID	Molecular Therapy - Nucleic Acids	de_DE
dcterms.isPartOf.ZS-Volume	13	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE